360 related articles for article (PubMed ID: 36675077)
1. A CRISPR-Cas Cure for HIV/AIDS.
Hussein M; Molina MA; Berkhout B; Herrera-Carrillo E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675077
[TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy.
Koujah L; Shukla D; Naqvi AR
Semin Cell Dev Biol; 2019 Dec; 96():53-64. PubMed ID: 30953741
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
4. Updates on CRISPR-based gene editing in HIV-1/AIDS therapy.
Zhang Z; Hou W; Chen S
Virol Sin; 2022 Feb; 37(1):1-10. PubMed ID: 35234622
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Cas based antiviral strategies against HIV-1.
Wang G; Zhao N; Berkhout B; Das AT
Virus Res; 2018 Jan; 244():321-332. PubMed ID: 28760348
[TBL] [Abstract][Full Text] [Related]
6. Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.
Huang Z; Tomitaka A; Raymond A; Nair M
Gene Ther; 2017 Jul; 24(7):377-384. PubMed ID: 28471431
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections.
Wahid B; Usman S; Ali A; Saleem K; Rafique S; Naz Z; Ahsan Ashfaq H; Idrees M
Viral Immunol; 2017 Oct; 30(8):552-559. PubMed ID: 28825529
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-CAS Replacing Antiviral Drugs against HIV: An Update.
Hashmat R; Yousaf MZ; Rahman Z; Anjum KM; Yaqoob A; Imran M
Crit Rev Eukaryot Gene Expr; 2020; 30(1):77-83. PubMed ID: 32421986
[TBL] [Abstract][Full Text] [Related]
9. Antiviral Goes Viral: Harnessing CRISPR/Cas9 to Combat Viruses in Humans.
Soppe JA; Lebbink RJ
Trends Microbiol; 2017 Oct; 25(10):833-850. PubMed ID: 28522157
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Cas attack of HIV-1 proviral DNA can cause unintended deletion of surrounding cellular DNA.
Liu Y; Binda CS; Berkhout B; Das AT
J Virol; 2023 Dec; 97(12):e0133423. PubMed ID: 37982648
[TBL] [Abstract][Full Text] [Related]
11. The CRISPR-Cas9 induced CCR5 Δ32 mutation as a potent gene therapy methodology for resistance to HIV-1 variant: a review.
Saifullah M; Laghzaoui O; Ozyahyalar H; Irfan A
Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2430-2463. PubMed ID: 38567606
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas Targeting of Host Genes as an Antiviral Strategy.
Chen S; Yu X; Guo D
Viruses; 2018 Jan; 10(1):. PubMed ID: 29337866
[TBL] [Abstract][Full Text] [Related]
13. CRISPR/CAS as a Powerful Tool for Human Immunodeficiency Virus Cure: A Review.
Vasconcelos Komninakis S; Domingues W; Saeed Sanabani S; Angelo Folgosi V; Neves Barbosa I; Casseb J
AIDS Res Hum Retroviruses; 2024 Jun; 40(6):363-375. PubMed ID: 38164106
[TBL] [Abstract][Full Text] [Related]
14. Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy.
Herskovitz J; Hasan M; Patel M; Kevadiya BD; Gendelman HE
Methods Mol Biol; 2022; 2407():429-445. PubMed ID: 34985679
[TBL] [Abstract][Full Text] [Related]
15. CRISPR based genome editing and removal of human viruses.
Chen YC
Prog Mol Biol Transl Sci; 2021; 179():93-116. PubMed ID: 33785179
[TBL] [Abstract][Full Text] [Related]
16. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy.
Xiao Q; Guo D; Chen S
Front Cell Infect Microbiol; 2019; 9():69. PubMed ID: 30968001
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9 Mediated Exonic Disruption for HIV-1 Elimination.
Herskovitz J; Hasan M; Patel M; Blomberg WR; Cohen JD; Machhi J; Shahjin F; Mosley RL; McMillan J; Kevadiya BD; Gendelman HE
EBioMedicine; 2021 Nov; 73():103678. PubMed ID: 34774454
[TBL] [Abstract][Full Text] [Related]
18. An RNA-Directed Gene Editing Strategy for Attenuating the Infectious Potential of Feline Immunodeficiency Virus-Infected Cells: A Proof of Concept.
Murphy BG; Wolf T; Vogel H; Castillo D; Woolard K
Viruses; 2020 May; 12(5):. PubMed ID: 32380756
[TBL] [Abstract][Full Text] [Related]
19. An overview: CRISPR/Cas-based gene editing for viral vaccine development.
Bhujbal S; Bhujbal R; Giram P
Expert Rev Vaccines; 2022 Nov; 21(11):1581-1593. PubMed ID: 35959589
[TBL] [Abstract][Full Text] [Related]
20. Plant Viruses: From Targets to Tools for CRISPR.
Varanda CM; Félix MDR; Campos MD; Patanita M; Materatski P
Viruses; 2021 Jan; 13(1):. PubMed ID: 33478128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
